Ann: Updated Strategy and Investor Presentation, page-97

Sure
I’m waiting to see how things pan out
I’ve said I think the drug has promise
The internal upheavals in the last 12 months haven’t helped and I consider 220 a new drug far as regulators go - so although past data is positive - all the steps in the process are still needed. Thus I believe there may be an ideal time in my mind to invest with less risk . Someone commented “ I sit in the middle of the back seat “ ( chuckled at that )
I would think any partnership is a while away . Why would they at this early stage .? I would imagine an eyes on the company would let you spend your own cash first .
I’ve talked about “ retail “ reliance .
As I said many moons ago I found it odd that a company rep engaged so much with hot copperites and that’s what intrigued me initially about the company ( I wondered how much that influenced investors- seems to be a merry band with the number of likes to news , posts etc ) . I accepted your reasoning about informing the masses and believe your intention is good hearted . I’ve followed the story since .

Turn the ship and you never know I might invest .

Now is a board seat logical for you ?